Clinical experience and future directions for low-density lipoprotein apheresis in the United States.

@article{Gordon1997ClinicalEA,
  title={Clinical experience and future directions for low-density lipoprotein apheresis in the United States.},
  author={Bruce R. Gordon and Stuart D Saal},
  journal={Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis},
  year={1997},
  volume={1 3},
  pages={249-52}
}
The United States Liposorber Study was a 22 week randomized controlled study of low-density lipoprotein (LDL) apheresis with an optional follow-up phase. The procedure was found to acutely lower LDL cholesterol by up to 81%, have good tolerability, and produce a reduction in the frequency of cardiovascular events. Studies outside the United States have found therapy with LDL apheresis to be associated with a favorable clinical outcome including improved myocardial perfusion, but variable… CONTINUE READING

Similar Papers

Loading similar papers…